compounded tirzepatide weight loss results Effectiveness & Biomarker Context Tirzepatide for Medical Weight Loss

Consider lowering your dose if the reaction started after a dose increase

This guideline helps ensure that patients receive effective treatment without unnecessary exposure to potential side effects

Semaglutide carries a boxed warning for risk of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), and is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Presented for research literature review only Nazar-Stewart V et al

Tirzepatide may suit qualifying adults who want a medication that has produced greater average weight loss in direct clinical trials